Research Study in Patients With Severe Ulcerative Colitis
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate an intravenous (by injection) investigational
medication to treat severe ulcerative colitis refractory to steroid therapy. The research is
being conducted at up to 8 clinical research sites in the US and is open to both men and
women ages 18 to 70 years old. Participants in the study will have a number of visits to a
research site. All study-related care and medication is provided to qualified participants at
no cost: this includes all visits, examinations and laboratory work.